The FDA just approved a pill for postpartum depression. Here's what that means

Postpartum depression is one of the most common complications of childbirth, affecting about a half million Americans each year. It’s among the leading causes of pregnancy-related death. Now, the FDA has approved the first pill for treating postpartum depression. Patricia Kinser, co-chair of perinatal mental health research at VCU’s Institute for Women’s Health, joins John Yang to discuss.

Related Keywords

United States ,Americans ,American ,Patricia Kinser ,John Yang ,Drug Administration ,Institute For Women Health ,Virginia Commonwealth University School Of Nursing ,Centers For Disease ,Disease Control ,Perinatal Mental Health Research ,Virginia Commonwealth University ,Virginia Commonwealth University School ,Maternal Depression ,Maternal Health ,Mental Health Care ,Postpartum Depression ,Pregnancy ,Health ,